tiprankstipranks
Trending News
More News >
Biosynex SA (DE:0DL)
:0DL

Biosynex SA (0DL) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Biosynex SA has a market cap or net worth of €8.68M. The enterprise value is ―.
Market Cap€8.68M
Enterprise Value

Share Statistics

Biosynex SA has 18,748,032 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,748,032
Owned by Insiders
Owned by Institutions

Financial Efficiency

Biosynex SA’s return on equity (ROE) is -0.54 and return on invested capital (ROIC) is -14.02%.
Return on Equity (ROE)-0.54
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-14.02%
Return on Capital Employed (ROCE)-0.19
Revenue Per Employee196.50K
Profits Per Employee-84.27K
Employee Count515
Asset Turnover0.52
Inventory Turnover1.34

Valuation Ratios

The current PE Ratio of Biosynex SA is ―. Biosynex SA’s PEG ratio is -0.03.
PE Ratio
PS Ratio0.18
PB Ratio0.23
Price to Fair Value0.23
Price to FCF-1.24
Price to Operating Cash Flow-0.65
PEG Ratio-0.03

Income Statement

In the last 12 months, Biosynex SA had revenue of 101.20M and earned -43.30M in profits. Earnings per share was -3.32.
Revenue101.20M
Gross Profit-20.00M
Operating Income-21.10M
Pretax Income-38.43M
Net Income-43.30M
EBITDA-17.83M
Earnings Per Share (EPS)-3.32

Cash Flow

In the last 12 months, operating cash flow was -10.12M and capital expenditures -4.84M, giving a free cash flow of -14.96M billion.
Operating Cash Flow-10.12M
Free Cash Flow-14.96M
Free Cash Flow per Share-0.80

Dividends & Yields

Biosynex SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.27
52-Week Price Change-63.85%
50-Day Moving Average0.56
200-Day Moving Average1.09
Relative Strength Index (RSI)36.64
Average Volume (3m)3.00

Important Dates

Biosynex SA upcoming earnings date is ―, ―.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

Biosynex SA as a current ratio of 0.75, with Debt / Equity ratio of 77.51%
Current Ratio0.75
Quick Ratio0.37
Debt to Market Cap3.31
Net Debt to EBITDA-2.49
Interest Coverage Ratio-3.40

Taxes

In the past 12 months, Biosynex SA has paid -1.40M in taxes.
Income Tax-1.40M
Effective Tax Rate-0.04

Enterprise Valuation

Biosynex SA EV to EBITDA ratio is -3.29, with an EV/FCF ratio of -5.10.
EV to Sales0.75
EV to EBITDA-3.29
EV to Free Cash Flow-5.10
EV to Operating Cash Flow-7.54

Balance Sheet

Biosynex SA has €9.69M in cash and marketable securities with €62.46M in debt, giving a net cash position of -€52.77M billion.
Cash & Marketable Securities€9.69M
Total Debt€62.46M
Net Cash-€52.77M
Net Cash Per Share-€2.81
Tangible Book Value Per Share-€2.50

Margins

Gross margin is -19.76%, with operating margin of -20.85%, and net profit margin of -42.79%.
Gross Margin-19.76%
Operating Margin-20.85%
Pretax Margin-37.97%
Net Profit Margin-42.79%
EBITDA Margin-22.92%
EBIT Margin-22.92%

Analyst Forecast

The average price target for Biosynex SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score